GeNeuro is developing a new approach to the treatment of diseases associated with human endogenous retrovirus expression with a focus on diseases of the nervous system and autoimmune diseases.
GeNeuro
Scientific Publications
MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment.
Read more